摘要:
The invention relates to the new antibiotic Lysolipin including two components X and I, and derivatives thereof. Lysolipin is formed when the strain Streptomyces violaceoniger (Waksman et Curtis) Waksman et Henrici Tu 96, which strain has been deposited under the reference NRRL 8097 at the Northern Regional Laboratory, U.S. Department of Agriculture, Peoria, Illinois, is cultured in a nutrient medium. The structural formulae of the 2 components are ##STR1## Lysolipin I and X and their derivatives have antibacterial activity and are effective against yeast - like fungi, such as Candida albicans. Their antibiotic action probably depends on an inhibition of the cell wall synthesis.
摘要翻译:本发明涉及包含两种组分X和I的新型抗生素赖溶脂蛋白及其衍生物。 当菌株Streptomyces violaceoniger(Waksman et Curtis)Waksman et HenriciTü96将菌株以参考文献NRRL 8097保藏在美国伊利诺伊州皮奥里亚州的美国农业部北部地区实验室时,形成溶纤剂,培养于营养培养基 。 2种成分的结构式为Lysolipin I,Lysolipin X Lysolipin I和X及其衍生物具有抗菌活性,对酵母菌真菌如白色念珠菌有效。 它们的抗生素作用可能取决于细胞壁合成的抑制。
摘要:
Bafilomycins of the formula ##STR1## in which R.sup.1 is hydrogen or CH.sub.3, andR.sup.2 is hydrogen, or the group ##STR2## are produced by culturing certain streptomyces, e.g. Tu 1922, Tu 2437 and Tu 2599. Those wherein at least one of the OH groups is acylated are new. The compounds are pesticidally active.